Among Alzheimer ‘s victims, 40% to 65% have a genetic variant called APOE4. Scientists have long known that this variant significantly increases the risk of neurodegenerative diseases, especially when one inherits a copy of APOE4 from both parents, but they are still learning to explain the molecular mechanisms of APOE4 action. A study published in…
CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, and custom synthesis to the science community, now provides custom glycosylation of antibodies service for research use. Antibodies are important components of many diseases’ protective immune responses, acting as cell-associated and soluble receptors for foreign substances. Variable domains (F(ab’)2) and constant…